Wickström, Malin
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. [electronic resource]
- Nature communications Nov 2015
- 8904 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 2041-1723
Standard No.: 10.1038/ncomms9904 doi
Subjects--Topical Terms: Animals Antineoplastic Agents--pharmacology Benzeneacetamides--pharmacology Brain Neoplasms--drug therapy Camptothecin--analogs & derivatives Celecoxib--pharmacology Cisplatin--pharmacology Colorectal Neoplasms--drug therapy DNA Modification Methylases--genetics DNA Repair Enzymes--genetics Dacarbazine--analogs & derivatives Doxorubicin--pharmacology Drug Resistance, Neoplasm--genetics Flow Cytometry Gene Expression Profiling Gene Expression Regulation, Neoplastic--drug effects Glioma--drug therapy Glucose-6-Phosphate Isomerase Heterocyclic Compounds, 3-Ring--pharmacology Humans Immunoblotting Immunohistochemistry Irinotecan Medulloblastoma--drug therapy Mice Neoplasm Transplantation Neoplasms--drug therapy Neuroblastoma--drug therapy Pyrans--pharmacology Pyrazines--pharmacology Pyridines--pharmacology Real-Time Polymerase Chain Reaction Sulfones--pharmacology Temozolomide Triazoles--pharmacology Tumor Suppressor Proteins--genetics Vincristine--pharmacology Wnt Proteins--genetics Wnt Signaling Pathway--drug effects beta Catenin--genetics